Ceribell, Inc.
For the period ended Sep 30, 2026. Filed Nov 3, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 3, 2026
CBLL$27.48-0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Statements of Cash Flows
(in thousands)
| Nine months ended September 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash flows from operating activities | ||
| Net loss | $(60,357) | $(39,885) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization expense | 733 | 1,050 |
| Noncash lease expense | (36) | (76) |
| Stock-based compensation expense | 16,820 | 8,864 |
| Amortization of debt discount and accretion of premium on term loans | 341 | 308 |
| Accretion (amortization) of discount and premium on marketable securities | (1,701) | (1,389) |
| Loss on disposal of property and equipment and recorders | 115 | 79 |
| Loss on debt extinguishment | 1,549 | — |
| Changes in operating assets and liabilities: | ||
| Accounts receivable, net | (2,739) | (1,356) |
| Inventory | 333 | 913 |
| Prepaid expenses and other current assets | (85) | 391 |
| Contract costs | 322 | (627) |
| Accrued interest on marketable securities | 242 | — |
| Other non-current assets | 17 | (221) |
| Accounts payable | (444) | 1,156 |
| Accrued liabilities and other current liabilities | (738) | 748 |
| Contract liabilities and deferred revenue | 129 | 11 |
| Other liabilities, long-term | 261 | — |
| Net cash used in operating activities | (45,238) | (30,034) |
| Cash flows from investing activities | ||
| Purchases of recorder components and recorders | (1,563) | (382) |
| Purchases of property and equipment | (242) | (588) |
| Purchases of marketable securities | (88,335) | (188,775) |
| Proceeds from sales of marketable securities | 15,299 | — |
| Proceeds from maturities of marketable securities | 117,500 | 45,500 |
| Net cash provided by (used in) investing activities | 42,659 | (144,245) |
| Cash flows from financing activities | ||
| Proceeds related to employee stock plans | 6,039 | 3,798 |
| Debt issuance cost | (547) | (150) |
| Proceeds from revolving line of credit | 40,000 | — |
| Payments on revolving line of credit | (20,000) | — |
| Payments on term loan debt | (20,000) | — |
| Payments on debt extinguishment | (1,400) | — |
| Net cash provided by financing activities | 4,092 | 3,648 |
| Net increase (decrease) in cash and cash equivalents | 1,513 | (170,631) |
| Cash and cash equivalents, beginning of period | 40,476 | 194,370 |
| Cash and cash equivalents, end of period | $41,989 | $23,739 |
| Supplemental disclosure of cash flow information | ||
| Cash paid for interest | $1,141 | $1,430 |
| Property and equipment included in accounts payable and accrued expenses | 96 | 27 |
| Recorder components included in accounts payable and accrued expenses | 19 | 40 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.